มอลโดวา - โรมาเนีย - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

centrul stiintific de producere "uzina chimico-farmaceutica borsceagov" sai - rifampicinum - capsule - 150 mg

มอลโดวา - โรมาเนีย - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

nijfarm sad - chloramphenicolum - ovule - 250 mg

โรมาเนีย - โรมาเนีย - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

sanofi pasteur - franta - vaccin tifoidic, polizaharidic purificĂ - sol. inj. - vaccinuri bacteriene vaccinuri tifoidice

มอลโดวา - โรมาเนีย - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

merck sharp & dohme idea gmbh - vaccin rotavirus, viu, pentavalentă - soluţie orală - 1 doză

มอลโดวา - โรมาเนีย - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

glaxosmithkline biologicals s.a. - vaccin rotavirus - suspensie orală

สหภาพยุโรป - โรมาเนีย - EMA (European Medicines Agency)

laboratorios lesvi s.l. - fumarat de dimetil - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

สหภาพยุโรป - โรมาเนีย - EMA (European Medicines Agency)

sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - imunosupresoare - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).

มอลโดวา - โรมาเนีย - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

merck sharp & dohme idea gmbh - vaccin rotavirus, viu, pentavalentă - soluţie orală - 1 doză

มอลโดวา - โรมาเนีย - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

glaxosmithkline biologicals s.a. - vaccin difteric, tetanic, pertussis, hepatitic b, poliomielitic dacă haemophilus influenzae tip b - ... - pulbere si suspensie pentru suspensie injectabila - 1 doza

สหภาพยุโรป - โรมาเนีย - EMA (European Medicines Agency)

novartis europharm limited - secukinumab - arthritis, psoriatic; psoriasis; spondylitis, ankylosing - imunosupresoare - plaque psoriasiscosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults and children from the age of 6 years old who are candidates for systemic therapy. hidradenitis suppurativa (hs)cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic hs therapy. psoriazică arthritiscosentyx, singur sau în asociere cu metotrexat (mtx), este indicat pentru tratamentul artritei psoriazice active la pacienții adulți, atunci când răspunsul la precedenta modificare a bolii anti-reumatice droguri (marmb) a fost terapia inadecvată. spondilartrită axială (axspa)spondilita anchilozantă (ca, radiografic spondilartrită axială)cosentyx este indicat pentru tratamentul de spondilită anchilozantă activă la adulți care au răspuns inadecvat la terapia convențională. non-radiographic axial spondyloarthritis (nr-axspa)cosentyx is indicated for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) evidence in adults who have responded inadequately to non steroidal anti inflammatory drugs (nsaids). juvenile idiopathic arthritis (jia)enthesitis-related arthritis (era)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active enthesitis-related arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. juvenile psoriatic arthritis (jpsa)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.